课题基金 / 基金详情

A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome

A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
一项评估产科抗磷脂综合征妊娠患者补体激活的前瞻性研究
批准号:
405079
负责人:
Skeith Leslie
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-05-01 至 2022-05-01

项目摘要

项目成果

Skeith Leslie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antiphospholipid syndrome (APS) is an autoimmune disease that can lead to blood clots (thrombosis) or complications in pregnancy such as pregnancy loss, pre-eclampsia or intrauterine growth restriction because of placental insufficiency. The cause of APS
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
  • 批准号:
    498295
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Skeith Leslie
  • 依托单位:
A prospective cohort study evaluating peripartum anticoagulation management among pregnant women with VTE and its impact on patient outcomes
  • 批准号:
    434526
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.06万
  • 财政年份:
    2020
  • 负责人:
    Skeith Leslie
  • 依托单位:
海外基金